Updated just now · Live
Stock analysis, price data, and AI-powered insights for Tonix Pharmaceuticals Holding Corp (TNXP).
Tonix Pharmaceuticals Holding Corp operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for TNXP.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). TNXP Stock Intelligence Report. [stoxpulse.com/stocks/tnxp]
Disclaimer: The information on this page about Tonix Pharmaceuticals Holding Corp (TNXP) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Tonix Pharmaceuticals Holding Corp.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Tonix Pharmaceuticals Announces Publication Of The...
6d ago
Tonix Pharmaceuticals Announces Publication of Ste...
6d ago
StoxPulse AI results for TNXP: Pulse Score 55.5/100. Primary sentiment trends from 2 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$192.2M
P/E Ratio
—
EPS
$-3.59
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Tonix Pharmaceuticals Announces Publication Of The Paper "Steady-State Pharmacokinetic Properties Of TNX-102 SL, A Sublingual Tablet Formulation Of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing In Healthy Volunteers: A Randomized, Open-label Trial," In The Journal 'Clinical Pharmacology In Drug Development'
Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development